Eradivir
0 followers
About Eradivir
Eradivir is a biotechnology company developing drugs that bind to diseased cells, guiding the immune system to fight disease. Their lead molecule, EV25, is a small molecule based Bispecific Antigenic immuno-Therapy (BAiT) technology that targets influenza and other diseases.
Recent News
No recent news for this company.